Free Trial

Atria Wealth Solutions Inc. Buys 2,034 Shares of Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • Atria Wealth Solutions Inc. increased its stake in Astera Labs, Inc. by 81.1% to a total of 4,543 shares worth $271,000 in the most recent quarter.
  • Astera Labs reported a quarterly earnings per share of $0.44, exceeding expectations by $0.11, with a year-over-year revenue growth of 149.5%.
  • Insiders, including CEO Jitendra Mohan, sold significant shares on August 7th, resulting in a 25.31% decrease in his ownership, while company insiders collectively sold 2,329,686 shares worth $273.5 million over the last ninety days.
  • Need better tools to track Astera Labs? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Atria Wealth Solutions Inc. boosted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 81.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,543 shares of the company's stock after purchasing an additional 2,034 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in Astera Labs were worth $271,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC raised its stake in Astera Labs by 318.9% during the 4th quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company's stock valued at $240,873,000 after purchasing an additional 1,384,498 shares during the period. Driehaus Capital Management LLC raised its stake in Astera Labs by 16,640.4% during the 4th quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock valued at $175,408,000 after purchasing an additional 1,316,419 shares during the period. Bank of Nova Scotia raised its stake in Astera Labs by 3,742.2% during the 1st quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock valued at $57,546,000 after purchasing an additional 939,300 shares during the period. Polar Capital Holdings Plc bought a new stake in Astera Labs during the 4th quarter valued at approximately $126,812,000. Finally, BNP Paribas Financial Markets raised its stake in Astera Labs by 4,172.8% during the 4th quarter. BNP Paribas Financial Markets now owns 816,619 shares of the company's stock valued at $108,161,000 after purchasing an additional 797,507 shares during the period. Institutional investors own 60.47% of the company's stock.

Astera Labs Stock Down 5.1%

ALAB traded down $9.5210 during trading hours on Tuesday, reaching $176.9090. 2,070,183 shares of the company's stock traded hands, compared to its average volume of 4,954,038. The firm has a 50-day moving average price of $117.37 and a 200 day moving average price of $90.72. Astera Labs, Inc. has a 52-week low of $36.85 and a 52-week high of $199.47. The firm has a market capitalization of $29.41 billion, a PE ratio of 314.90, a PEG ratio of 4.71 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same quarter in the previous year, the business earned $0.13 EPS. Astera Labs's revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research analyst reports. Northland Capmk cut Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday. Barclays restated an "overweight" rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. Morgan Stanley raised their price target on Astera Labs from $125.00 to $155.00 and gave the company an "overweight" rating in a report on Wednesday, August 6th. Finally, Northland Securities cut Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price for the company. in a report on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $129.13.

Check Out Our Latest Analysis on Astera Labs

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the sale, the chief executive officer directly owned 450,001 shares of the company's stock, valued at $76,648,670.33. The trade was a 25.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,176,436 shares of company stock worth $259,714,061 over the last quarter. Insiders own 12.50% of the company's stock.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines